Invention Grant
- Patent Title: Methods for identification, assessment, prevention, and treatment of metabolic disorders using PM20D1 and N-lipidated amino acids
-
Application No.: US15770648Application Date: 2016-10-28
-
Publication No.: US12194080B2Publication Date: 2025-01-14
- Inventor: Bruce M. Spiegelman , Jonathan Z. Long
- Applicant: Dana-Farber Cancer Institute, Inc.
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Foley Hoag LLP
- International Application: PCT/US2016/059289 WO 20161028
- International Announcement: WO2017/075329 WO 20170504
- Main IPC: A61K38/50
- IPC: A61K38/50 ; A61P3/10 ; C12N9/80 ; C12Q1/44 ; G01N33/50
Abstract:
The present invention relates to methods for identifying, assessing, preventing, and treating metabolic disorders and modulating metabolic processes using PM20D1 and N-lipidated amino acids.
Public/Granted literature
Information query
IPC分类:
